Werewolf Therapeutics Inc...

NASDAQ: HOWL · Real-Time Price · USD
1.35
0.03 (2.27%)
At close: Aug 15, 2025, 2:36 PM

Werewolf Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
111M 134.34M 129.31M 157.53M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
1.22M 21.02M 1.21M 1.21M
Other Long-Term Assets
320K 594K 1.38M 649K
Receivables
n/a 1.35M 6.93M n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
2.07M 2.68M 3.96M n/a
Total Current Assets
113.07M 138.37M 140.2M 161.07M
Property-Plant & Equipment
12.32M 14.85M 17.45M 16.32M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
13.86M 36.46M 20.05M 18.18M
Total Assets
126.93M 174.83M 160.25M 179.25M
Account Payables
3.04M 1.34M 1.22M 2.04M
Deferred Revenue
n/a 907K 6.53M n/a
Short-Term Debt
1.56M 6.67M 2.08M 1.07M
Other Current Liabilities
9.03M 3.63M 8.93M 5.49M
Total Current Liabilities
15.18M 19.38M 23.99M 11.87M
Long-Term Debt
26.09M 32.66M n/a 14.59M
Other Long-Term Liabilities
2.83M 433K 1.32M -14.59M
Total Long-Term Liabilities
38.36M 44.08M 13.92M 14.59M
Total Liabilities
53.54M 63.46M 37.91M 26.46M
Total Debt
37.09M 51.92M 14.68M 15.66M
Common Stock
5K 4K 3K 2K
Retained Earnings
-414.59M -344.07M -306.7M -252.9M
Comprehensive Income
n/a n/a n/a -179.25M
Shareholders Equity
73.39M 111.37M 122.34M 152.79M
Total Investments
1.22M 21.02M 1.21M 1.21M